Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated : 05/19/2022

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Recurrent Postoperative Lung Cancer with Tumor Shrinkage after Discontinuation of Pembrolizumab-A Case Report.

Condition: Recurrent Postoperative Lung Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Treatment Used: Discontinuation of Pembrolizumab
Number of Patients: 1
Published: January 20, 2022
View publication
Summary: Recurrent Postoperative Lung Cancer with Tumor Shrinkage after Discontinuation of Pembrolizumab-A Case Report.

Complete remission of combined pulmonary large cell neuroendocrine carcinoma: a case report.

Condition: Pulmonary Large Cell Neuroendocrine Carcinoma
Journal: The Journal of international medical research
Treatment Used: Albumin-Bound Paclitaxel plus Platinum-Based Chemotherapy with Radiotherapy and Durvalumab
Number of Patients: 1
Published: November 05, 2021
View publication
Summary: Complete remission of combined pulmonary large cell neuroendocrine carcinoma: a case report.

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.

Condition: Non-Small Cell Lung Cancer (NSCLC)
Journal: BMC pulmonary medicine
Treatment Used: Immune Checkpoint Inhibitors (ICIs)
Number of Patients: 175
Published: October 03, 2021
View publication
Summary: Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.

Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.

Condition: Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.
Journal: Asian Pacific journal of cancer prevention : APJCP
Treatment Used: Immunotherapy
Number of Patients: 37
Published: February 28, 2021
View publication
Summary: Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.

Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung.

Condition: Large-Cell Neuroendocrine Lung Carcinoma (aLCNEC)
Journal: Journal for immunotherapy of cancer
Treatment Used: Immune Checkpoint Inhibitors (ICI)
Number of Patients: 125
Published: February 18, 2021
View publication
Summary: Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung.

Large cell neuroendocrine carcinoma of the lungs: case report and literature review.

Condition: Large cell neuroendocrine carcinoma (LCNEC) of Lungs
Journal: Annals of palliative medicine
Treatment Used: Surgery, Radiotherapy, Chemotherapy, and Immunotherapy
Number of Patients: 1
Published: October 17, 2020
View publication
Summary: Large cell neuroendocrine carcinoma of the lungs: case report and literature review.

Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study.

Condition: Treatment-Refractory Non-Small-Cell Lung Cancer (NSCLC)
Journal: Journal for immunotherapy of cancer
Treatment Used: Adoptive Transfer of Zoledronate-Expanded Autologous V?9V?2 T-Cells
Number of Patients: 25
Published: September 19, 2020
View publication
Summary: Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study.

Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study.

Condition: Combined Small Cell Lung Cancer
Journal: Lung cancer (Amsterdam, Netherlands)
Treatment Used: Radical R0 Surgery
Number of Patients: 181
Published: June 28, 2020
View publication
Summary: Clinical characteristics and prognostic factors of surgically resected combined small cell lung cancer: a retrospective study.

SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma: Phase 1 study.

Condition: Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma
Journal: Lung cancer (Amsterdam, Netherlands)
Treatment Used: SC-002
Number of Patients: 35
Published: May 22, 2020
View publication
Summary: SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma: Phase 1 study.

Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy.

Condition: Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal: Advances in therapy
Treatment Used: Immunotherapy
Number of Patients: 60
Published: May 22, 2020
View publication
Summary: Incidence of Pericardial Effusion in Patients with Advanced Non-Small Cell Lung Cancer Receiving Immunotherapy.

Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease.

Condition: Lung Cancer combined with Interstitial Lung Disease
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Treatment Used: Surgery
Number of Patients: 23
Published: May 21, 2020
View publication
Summary: Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease.

Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC).

Condition: Large Cell Neuroendocrine Tumors of Lung
Journal: Lung cancer (Amsterdam, Netherlands)
Treatment Used: Immune Check-point Inhibitors
Number of Patients: 37
Published: March 24, 2020
View publication
Summary: Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC).
Showing 1-12 of 36

Last Updated : 05/19/2022